Unknown

Dataset Information

Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances.


ABSTRACT: The degeneration of light-detecting rod and cone photoreceptors in the human retina leads to severe visual impairment and ultimately legal blindness in millions of people worldwide. Multiple therapeutic options at different stages of degeneration are being explored but the majority of ongoing clinical trials involve adeno-associated viral (AAV) vector-based gene supplementation strategies for select forms of inherited retinal disease. Over 300 genes are associated with inherited retinal degenerations and only a small proportion of these will be suitable for gene replacement therapy. However, while the origins of disease may vary, there are considerable similarities in the physiological changes that occur in the retina. When early therapeutic intervention is not possible and patients suffer

SUBMITTER: McClements ME 

PROVIDER: S-EPMC7686539 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature